Home
/
MOONLAKE IMMUNOTHERAPEUTICS (MLTX)
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Technical Analysis
Updated: 2026-03-17 00:36 UTC · Last close: 16.73 (-2.34%)
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) closed at 16.73 (-2.34%). Price has recovered above the 50-day average but remains below the 200-day average, so the short-term tone is improving while the larger structure is still rebuilding. 20-day momentum is positive at +6.09%, with price is trading in the lower part of its roughly 52-week range (6.24–61.99), while ATR14 volatility is elevated at roughly 4.87% of price. RSI(14) is 44.3, leaving momentum in a fairly neutral range. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram is negative and weakening further, which reflects continued downside pressure. The chart is currently flagging: pat_inverse_hs. The nearest decision zone is framed by support at 14.72 and resistance at 16.88. A move through resistance would improve the short-term technical tone, while a loss of support would weaken the current structure. Latest fundamentals snapshot: Net income: -227.32M · EPS (basic): -3.53. The interactive view adds overlays, pattern context and broader chart structure for deeper review.
Fundamentals Snapshot
Source: sec
Company
MOONLAKE IMMUNOTHERAPEUTICS
Note: This is an algorithmic technical snapshot (not financial advice).